CPH •
Healthcare •
Medical Instruments & Supplies •
Quote as of 09/08/2026 16:59
Company Profile
IndustryMedical Instruments & Supplies
SectorHealthcare
ExchangeCPH
Market Capitalization104,548 mln
Float145 mln
Earnings Date11/03/2026
EPS
12.26
Robust
P / E
36.48
Overvalued
1-Year Forecast
473
Modest upside
Relative Strength
11
/ 100
Significantly lagging
Debt / Equity
1.78
High leverage
ROE
18.53
Healthy
Business Description
Founded in 1954 and based in Denmark, Coloplast develops and sells medical products that help people manage personal health conditions affecting the bladder, bowel, skin, and airways. The company serves patients across Europe, the United States, and other markets worldwide, offering solutions for ostomy care, catheterization, wound treatment, and voice restoration after throat surgery. It also makes surgical devices used to treat urological and gynecological conditions such as erectile dysfunction, urinary stones, and incontinence.
